Therapy Areas: Infectious Diseases
20 November 2018 - Roivant Sciences, a company that in-licenses late-stage drug candidates and develops them through subsidiaries, has signed a global licensing agreement with Korea-based iNtRON Biote...
19 November 2018 - - US-based biotechnology company Beam Therapeutics has appointed Carole Ho, M.D., chief medical officer and head of development at Denali Therapeutics, to the company's board o...
19 November 2018 - Public health agency the US Food and Drug Administration reported on Friday that it has approved Aemcolo (rifamycin) for the treatment of adult patients with travellers diarrhoea un...
9 November 2018 - - US-based clinical-stage company Vedanta Biosciences has released preclinical data for VE800, the company's orally-administered, live biotherapeutic product candidate in immuno...
8 November 2018 - - Austrian immunomodulation therapies developer Themis Bioscience has published the Phase 2 results of its lead vaccine candidate (MV-CHIK) in The Lancet, the company said....
5 November 2018 - Bavarian Nordic A/S (CPH:BAVA) (OTC: BVNRY), a fully integrated biotechnology company, announced on Friday the dosing of the first patient in a clinical study evaluating CV301, the c...
Related Headlines